Rifai, Abdalla

EXACTCYTE

Cells for medical or clinical use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals;

MYSANO

Anti-diabetic pharmaceuticals; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, lipid lowering agents; Plant extracts for medical, veterinary and pharmaceutical purposes; Synthetic peptides for pharmaceutical purposes; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension;The foreign wording in the mark translates into English as My Healthy.;

SERAPIS

Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Cells for medical or clinical use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, lipid lowering agents;

SURFEIT

Diet capsules; Diet pills; Dietary drink mix for use as a meal replacement; Dietary supplemental drinks; Food for medically restricted diets; Meal replacement and dietary supplement drink mixes; Meal replacement drinks; Nutritional drink mix for use as a meal replacement; Powdered nutritional supplement drink mix; Soy protein for use as a nutritional ingredient in various powdered and ready-to-drink beverages;